GSK poaches Boehringer veteran for drug development lead

Sep 18, 2018

GlaxoSmithKline has hired Chris Corsico from Boehringer Ingelheim. Corsico will become senior vice president development of GSK. 

Corsico, currently chief medical officer at Boehringer, will start at GSK in 2019 as the company changes up its research strategy. Corsico will report to research head Hal Barron.

Barron joined GSK at the start of 2018 as one of CEO Emma Walmsley's first hires.

Read the New York Times report

Don't miss your Daily Dose! Subscribe to the daily eNewsletter

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments